Skip to main content
. 2023 Sep 18;24(9):253. doi: 10.31083/j.rcm2409253

Table 3.

Between-Group Differences outcomes among Recipients of Mechanical and Biologic Valve in AVR cohort.

Aortic–valve replacement (50–70 yrs) Aortic–valve replacement (50–59 yrs) Aortic–valve replacement (60–70 yrs)
Bioprosthetic (n = 134) Mechanical (n = 324) p-value Bioprosthetic (n = 33) Mechanical (n = 237) p-value Bioprosthetic (n = 101) Mechanical (n = 87) p-value
Death 23 (80.4%) 49 (81.0%) 0.500 6 (77.0%) 34 (83.0%) 0.500 17 (81.9%) 15 (73.2%) 1.000
(15–yrs survival rate)
Crude model ref 0.83 (0.51–1.37) 0.469 ref 0.73 (0.31–1.75) 0.482 ref 1.00 (0.50–2.00) 1.000
HR (95% CI)
IPW model ref 1.12 (0.60–2.09) 0.725 ref 1.00 (0.35–2.92) 0.996 ref 1.11 (0.54–2.27) 0.777
HR (95% CI)
Cox HR ref 0.84 (0.45–1.56) 0.588 ref 0.55 (0.21–1.44) 0.222 ref 1.12 (0.56–2.25) 0.742
HR (95% CI)
Stroke (percentage) 16 (11.9%) 45 (13.9%) 0.999 3 (9.1%) 34 (14.3%) 0.6 13 (12.9%) 11 (12.6%) 0.800
Crude model ref 1.02 (0.57–1.82) 0.950 ref 1.35 (0.41–4.41) 0.623 ref 0.92 (0.41–2.07) 0.842
HR (95% CI)
IPW model ref 1.39 (0.64–3.02) 0.405 ref 2.02 (0.54–7.56) 0.296 ref 1.31 (0.53–3.22) 0.554
HR (95% CI)
Cox HR ref 1.09 (0.54–2.18) 0.808 ref 1.098 (0.34–3.60) 0.878 ref 1.69 (0.75–3.80) 0.203
HR (95% CI)
Bleeding (percentage) 10 (7.5%) 97 (29.9%) <0.001 4 (12.1%) 76 (32.1%) 0.06 6 (5.9%) 21 (24.1%) <0.001
Crude model ref 3.97 (2.07–7.62) <0.001 ref 2.54 (0.93–6.95) 0.07 ref 4.31 (1.74–10.71) 0.002
HR (95% CI)
IPW model ref 2.51 (1.06–5.93) 0.036 ref 2.11 (0.76–6.23) 0.176 ref 3.57 (1.36–9.36) 0.010
HR (95% CI)
Cox HR ref 3.07 (1.51–6.24) 0.002 ref 2.50 (0.88–7.09) 0.084 ref 3.48 (1.29–9.41) 0.014
HR (95% CI)

AVR, aortic valve replacement; HR, hazard ratio; CI, confidence interval; Crude model HR, analyzed in the univariate model, inverse probability-weighted (IPW) model HR, analyzed in IPW model; Cox HR: adjusted for demographic features, body mass index (BMI), history of hypertension, hyperlipidemia, diabetes, chronic obstructive pulmonary disease (COPD), stroke, atrial fibrillation (AF), coronary heart disease (CHD) and New York Heart Association (NYHA) class. ref refers to the reference in the model.